Sphera Funds Management Ltd. Nautilus Biotechnology, Inc. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.64 - $4.84 $2.22 Million - $4.07 Million
-840,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.5 - $5.3 $140,000 - $212,000
40,000 Added 5.0%
840,000 $3.65 Million
Q2 2021

Aug 17, 2021
BUY
$9.04 - $14.19 $7.23 Million - $11.4 Million
800,000 New
800,000 $8.08 Million

Others Institutions Holding NAUT

# of Institutions
86
Shares Held
64.3M
Call Options Held
1.9K
Put Options Held
100
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $297M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email